Disparities in PCV impact between different ethnic populations cohabiting in the same region: A systematic review of the literature
- PMID: 27443591
- DOI: 10.1016/j.vaccine.2016.07.004
Disparities in PCV impact between different ethnic populations cohabiting in the same region: A systematic review of the literature
Abstract
Background: Invasive pneumococcal disease (IPD) and pneumonia are major causes of morbidity, especially in developing countries. While pneumococcal disease rates differences between various populations are well known, data are scarce regarding disparities in PCV impact on pneumococcal disease rates between populations living in the same country.
Objective: The aim of this systematic literature review was to describe disparities in PCV impact between different populations.
Methods: A systematic literature search was performed using the PubMed database. Studies evaluating pneumococcal disease rates at any age were included. The search was limited to articles written in English and published between 2000 and 2015. Independent extraction of articles was performed by two authors (NS, SB-S). Search terms included: pneumococcus, pneumococcal disease, IPD, pneumonia, PCV, pneumococcal vaccine, population, race, ethnicity, differences, and disparity. We defined resource-poor populations as African-Americans, Aboriginal, Alaska natives and Navajo native-Americans populations compared with the respective resource-rich populations, including White, non-Aboriginal, non-Alaska natives and general US population.
Results: Eighteen articles meeting the selection criteria were identified; 17 regarding IPD and one regarding pneumonia. Nine articles compared IPD rates in African-Americans and Whites in the US, six compared Aboriginal and non-Aboriginal populations; two compared Alaska natives vs. non-native Alaskans in the US and one article compared Navajo native-Americans and general population in the US. Only minor difference where usually noted in the incidence rate ratios (IRRs) comparing pre- and post-PCV rates of IPD and pneumonia between resource rich and resource poor populations. In contrast, absolute rate reductions were higher in resource-poor compared with resource-rich populations.
Conclusion: While differences in IPD and pneumonia rates between resource-poor and resource-rich populations were decreased following PCV introduction, disparity is still apparent and is not fully eliminated in any of the studies. Younger (<2years) populations in resource-poor populations seem to benefit the most from PCV introduction.
Keywords: Differences; Disparity; Ethnicity; Invasive pneumococcal disease (IPD); Pneumococcal conjugate vaccine (PCV); Pneumococcal disease; Pneumococcal vaccine; Pneumonia; Population; Race; Streptococcus pneumoniae.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.Vaccine. 2017 May 19;35(22):2882-2891. doi: 10.1016/j.vaccine.2017.04.032. Epub 2017 Apr 24. Vaccine. 2017. PMID: 28449971 Review.
-
Disparities in Effectiveness of Pneumococcal Vaccine in Industrialized and Developing Countries: Is Vaccination Closing the Gap?Antibiot Khimioter. 2016;61(11-12):63-67. Antibiot Khimioter. 2016. PMID: 29558061 Review.
-
Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004977. doi: 10.1002/14651858.CD004977. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2009 Oct 07;(4):CD004977. doi: 10.1002/14651858.CD004977.pub2 PMID: 15495133 Updated. Review.
-
Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.Vaccine. 2018 Aug 28;36(36):5477-5484. doi: 10.1016/j.vaccine.2017.05.059. Epub 2017 Jun 1. Vaccine. 2018. PMID: 28579230
-
Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.Vaccine. 2013 Dec 17;32(1):133-45. doi: 10.1016/j.vaccine.2013.05.005. Epub 2013 May 16. Vaccine. 2013. PMID: 23684824 Review.
Cited by
-
Novel coenzyme Q6 genetic variant increases susceptibility to pneumococcal disease.Nat Immunol. 2024 Dec;25(12):2247-2258. doi: 10.1038/s41590-024-01998-4. Epub 2024 Nov 4. Nat Immunol. 2024. PMID: 39496954
-
Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments.Can Respir J. 2017;2017:2397429. doi: 10.1155/2017/2397429. Epub 2017 Mar 23. Can Respir J. 2017. PMID: 28424565 Free PMC article.
-
Epidemiology of invasive pneumococcal disease in indigenous and non-indigenous adults in northwestern Ontario, Canada, 2006-2015.BMC Infect Dis. 2018 Dec 4;18(1):621. doi: 10.1186/s12879-018-3531-9. BMC Infect Dis. 2018. PMID: 30514226 Free PMC article.
-
Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys.Lancet Glob Health. 2018 Dec;6(12):e1375-e1385. doi: 10.1016/S2214-109X(18)30383-8. Lancet Glob Health. 2018. PMID: 30420033 Free PMC article.
-
Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States.Expert Rev Vaccines. 2019 Apr;18(4):327-341. doi: 10.1080/14760584.2019.1582337. Epub 2019 Mar 20. Expert Rev Vaccines. 2019. PMID: 30759352 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous